Connect with us

Brands

Morepen Laboratories’ sugar-busting bargain hits Indian market

Published

on

MUMBAI: Morepen Laboratories has unleashed Empamore, a wallet-friendly weapon against Type 2 diabetes, heart failure and kidney disease that promises to shake up treatment for millions in the world’s diabetes capital.

With India groaning under the weight of 101 million diabetes cases, the pharmaceutical firm’s latest offering aims to deliver the same therapeutic punch as pricier alternatives at a fraction of the cost—a sweet deal for patients previously priced out of optimal care.

The new drug, empagliflozin, belongs to the coveted class of SGLT2 inhibitors and will be available in various formulations, including combinations with metformin. All products are manufactured at Morepen’s facilities, which boast the American regulator’s stamp of approval.

Advertisement

“At Morepen, we are dedicated to democratising healthcare by making world-class treatments accessible to all,” declared vice president of sales & marketing Ashutosh Sharma. “With Empamore, we are providing a trusted, high-quality diabetes treatment at nearly 90 per cent lower cost than existing brands, helping millions manage their condition effectively without financial strain.”

This aggressive pricing strategy aims to capture a hefty slice of India’s diabetes market, which is expected to grow at a robust 10.9 per cent compound annual growth rate as pre-diabetes cases swell to a staggering 136 million.

Morepen is no newcomer to the diabetes battleground. The company has already flooded the market with more than 12.33 million glucometers and a mind-boggling 1.65 billion blood glucose strips, establishing itself as a familiar name in medicine cabinets across the subcontinent.

Advertisement

The firm’s latest offering promises more than just glycaemic control, addressing cardiovascular and renal complications while packaging the pills in perforated strips for patients who might otherwise struggle with adherence.

With a global footprint spanning 82 countries, Morepen’s bargain-basement diabetes treatment may soon be sweetening the lives of patients far beyond Indian shores—proving that sometimes, the best medicine is the one you can actually afford.

Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Brands

Hyundai Venue crosses 1 lakh bookings, adds HX8 Diesel AT variant

New top-spec automatic diesel trim brings ventilated seats, OTA updates and paddle shifters.

Published

on

MUMBAI: Hyundai Venue just hit the jackpot and upgraded the prize because when you cross 1 lakh bookings, you don’t just celebrate, you throw in paddle shifters and ventilated seats for the ride. Hyundai Motor India Limited (HMIL) announced that the all-new Hyundai Venue has achieved 1 lakh bookings, cementing its strong position in the compact SUV segment. To mark the milestone and further enhance customer choice, the company introduced the new HX8 Diesel Automatic (AT) variant.

The HX8 Diesel AT is powered by the proven U2 1.5L CRDi diesel engine paired with a 6-speed automatic transmission. It adds a host of premium comfort, safety and convenience features, including:

  • Ventilated front seats
  • Dual-tone leatherette seats with VENUE branding
  • Electric 4-way driver seat adjust
  • Controller Over-the-Air (OTA) updates
  • Hyundai Bluelink connected car technology
  • Electric parking brake with auto hold
  • Rear disc brakes
  • Ambient lighting on crash pad and central console
  • Drive mode select (Eco, Normal, Sport)
  • Traction control modes (Sand, Mud, Snow)
  • Paddle shifters

HMIL, managing director & CEO Tarun Garg said, “We are delighted that the new Hyundai Venue has crossed 1 lakh bookings, reaffirming the strong trust Indian customers place in our brand. The introduction of the new HX8 Diesel Automatic variant further strengthens the Venue lineup, offering customers the perfect blend of diesel efficiency, torque-rich performance and effortless convenience.”

Backed by Hyundai’s extensive sales and service network, the Venue continues to appeal to buyers seeking a feature-rich, comfortable and future-ready compact SUV. The new variant reinforces HMIL’s focus on delivering advanced technology, safety, comfort and value while adapting to evolving customer preferences.

Advertisement

In a segment where bookings are the real horsepower, Hyundai isn’t just counting milestones, it’s handing drivers an automatic upgrade that makes every journey feel like the victory lap.

Continue Reading

Advertisement News18
Advertisement All three Media
Advertisement Whtasapp
Advertisement Year Enders

Copyright © 2026 Indian Television Dot Com PVT LTD

This will close in 20 seconds